Sepsis ImmunoScore

Sepsis ImmunoScore is a predictive software tool that analyzes up to 22 inputs from adult patients' electronic health records, including demographics, vitals, and lab values, to aid in the early detection of sepsis. It employs a random forest model to generate a risk score and categorize patients into four sepsis risk levels within 24 hours, providing feature attributions to support clinical decision-making.

Sepsis ImmunoScore is a cloud-based software designed as a predictive tool for adult patients suspected of having sepsis. It processes up to 22 distinct inputs derived from electronic health records, encompassing patient demographics, vital signs, laboratory values, and optionally, specific sepsis biomarkers. Utilizing a random forest machine learning model, the software generates a continuous risk score and categorizes patients into one of four risk levels for developing sepsis within the subsequent 24 hours, thereby assisting clinicians in the early identification and management of this critical condition. The development of the Sepsis ImmunoScore algorithm involved training and validation using retrospective data collected from multiple medical centers, where it successfully achieved predefined sensitivity and specificity targets. To foster transparency and support timely clinical decision-making in sepsis management, the tool incorporates feature attributions, which highlight the specific input variables that most significantly influenced an individual patient's risk score. It is intended to serve as an adjunctive aid to, rather than a replacement for, the clinical judgment exercised by healthcare professionals.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. What were the specific sensitivity and specificity values achieved during the multi-center validation, and how do these compare to existing sepsis screening tools or clinical judgment alone?; How does the Sepsis ImmunoScore model's performance vary across different patient subgroups (e.g., based on age, comorbidities, or initial presenting symptoms) not explicitly detailed as inputs?; Beyond feature attributions, what mechanisms are in place to help clinicians understand the model's reasoning, especially in cases where the risk score is unexpected or counterintuitive?; Has the integration of Sepsis ImmunoScore into clinical workflows demonstrated a measurable impact on patient outcomes, such as reduced time to antibiotic administration or decreased sepsis-related mortality rates, in prospective real-world studies?; Which of the optional sepsis biomarkers, when included, provide the most significant improvement in the model's predictive accuracy, and is there a minimum set of core inputs required for the tool to maintain reliable performance?